Address: 149 Commonwealth Drive, Menlo Park, CA 94025
Phone: 650-688-3270
Fax: 650-688-3218
Email: info@corcept.com
Website: www.corcept.com
Booth #: 313
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders. Korlym® (mifepristone) 300mg Tablets, a first generation GR antagonist, for the control of hyperglycemia associated with persistent Cushing syndrome is the company's first FDA-approved medication. www.corcept.com.
BACK